Head-to-head
BPC-157 vs TB-500
Both are tissue-repair peptides that get stacked together as the 'Wolverine stack.' BPC-157 works locally near injury sites with broad gut/tendon effect. TB-500 is systemic, mobilizing actin throughout the body for whole-system repair.
Side by side
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Mechanism | GH receptor upregulation, NO synthesis, angiogenesis | Actin polymerization, cell migration to injury sites |
| Best for | Localized injuries, gut healing, tendon | Systemic injuries, multiple sites, soft tissue |
| Origin | Gastric protective protein fragment | Thymosin β4 fragment (AA 17-23) |
| Dose | 250–500 mcg/day | 2 mg every other day |
| Frequency | Daily | EOD or 2x/week loading |
| Cycle | 8–12 weeks on / 4 weeks off | 8–9 weeks (4 loading + 4 maintenance) |
| Half-life | Short (minutes plasma) | Hours |
| Oral viable? | Yes for gut targets, high dose | No — breaks down |
| Stacks well with | TB-500, KPV, GHK-Cu | BPC-157 (mandatory) |
Who wins, by goal
Gut / digestive issues
BPC-157 originated as a gut-protective peptide. TB-500 doesn't act in this space.
Localized tendon / joint injury
Inject near injury site for direct action.
Systemic / multiple injury sites
TB-500 mobilizes throughout the body via actin pathways.
Cardiac / smooth muscle repair
Originated from cardiac thymosin research.
Stack together (most use cases)
Bachmeyer, Jones DC, Jay Campbell, JD Denham all recommend BPC + TB combined for full-spectrum recovery — 'Wolverine stack.'
Where the experts land
Universal endorsement from Bachmeyer, Jones DC, JD Denham, Trigili, Froese, Jay Campbell, Hunter Williams. Always recommended together for systemic recovery. BPC-157 has the broader use case (gut + injury); TB-500 amplifies systemic effect.
Bottom line
Don't pick one — run both. BPC-157 daily near targets + TB-500 every other day systemic. The 'Wolverine stack' is consensus for serious injury recovery in lifters and athletes.